Company: TELO
Filing Date: 2025-02-14
Form Type: S-3
Source: 0001493152-25-006943
Chunk: 19

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-3
Chunk 19
---
 may issue will specify the terms of the warrants, including:

● the title and aggregate number of the warrants;

● the price or prices at which the warrants will be issued;

● the title, amount and terms of the securities purchasable upon exercise of the warrants;

● the title, amount and terms of the securities offered with the warrants and the number of warrants issued with each such security;

● the date, if any, on and after which the warrants and the related securities will be separately transferable;

● the price at which the related securities may be purchased upon exercise of the warrants;

● the exercise period for the warrants;

● the minimum or maximum number of warrants which may be exercised at any one time;

● any applicable anti-dilution, redemption or call provisions;

● any applicable book-entry provisions; and

● any other terms of the warrants.

Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding-up, or to exercise voting rights, if any.

<div align='center'>DESCRIPTION OF UNITS</div>

As specified in the applicable prospectus supplement, we may issue units consisting of one or more shares of common stock, shares of preferred stock or warrants or any combination of such securities, including guarantees of any securities.

The applicable prospectus supplement and any other offering materials relating to any units issued under the registration statement of which this prospectus is a part will specify the terms of the units, including:

● the terms of the units and of any of the common stock, preferred stock and warrants comprising the units, including whether and under what circumstances the securities comprising the units may be traded separately;

● a description of the terms of any unit agreement governing the units; and

● a description of the provisions for the payment, settlement, transfer or exchange of the units.

| 13 |

<div align='center'>PLAN OF DISTRIBUTION</div>

We may sell the securities offered by this prospectus to one or more underwriters or dealers for resale, through agents, directly to purchasers or through a combination of any such methods of sale, including in at the market offerings into an existing trading market in accordance with Rule 415(a)(4) of the Securities Act. The name of any such underwriter, dealer or agent involved in the offer and sale of the securities, the amounts underwritten and the nature of its obligation to take the securities will